Halychpharm Logo

Halychpharm

A pharmaceutical manufacturer of finished medicines and plant-derived phytochemical substances.

GFARM | Ukrainian Stock Exchange

Overview

Corporate Details

ISIN(s):
UA4000105993
LEI:
Country:
Ukraine
Address:
Opryshkivska vulytsia 6, 79024 Lviv
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Halychpharm, a member company of the Arterium Corporation, is a pharmaceutical manufacturer specializing in finished medicinal products. The company is a key producer of phytochemical substances derived from the extraction of medicinal plant raw materials. Its portfolio includes a range of medications designed to meet various therapeutic needs, providing high-quality treatments to patients and consumers. Halychpharm supports the entire patient treatment journey, from developing new products for unmet medical needs to ensuring drug safety through pharmacovigilance.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Halychpharm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Halychpharm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Halychpharm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CHOSA Oncology AB Logo
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden
CHOSA
CHUGAI PHARMACEUTICAL CO., LTD. Logo
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan
4519
CHUKYOIYAKUHIN CO.,LTD. Logo
Direct-to-home service providing medicine boxes, health products, and daily necessities.
Japan
4558
Cidara Therapeutics, Inc. Logo
Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.
United States of America
CDTX
Cinclus Pharma Holding AB Logo
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden
CINPHA
Cingulate Inc. Logo
Developing once-daily, precision timed-release drugs for ADHD and anxiety.
United States of America
CING
CITIUS ONCOLOGY, INC. Logo
Commercializing LYMPHIR™, an FDA-approved targeted therapy for cutaneous T-cell lymphoma.
United States of America
CTOR
Citius Pharmaceuticals, Inc. Logo
Late-stage biopharma developing critical care products for oncology, infections, and stem cells.
United States of America
CTXR

Talk to a Data Expert

Have a question? We'll get back to you promptly.